Company Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Equities

6990

CNE1000062J1

Biotechnology & Medical Research

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per region

Ratings for Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Bio Therapeutic Drugs

SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.

Market Closed - Hong Kong S.E. Other stock markets 04:08:22 2024-05-10 am EDT			5-day change	1st Jan Change
189 ^HKD	+6.48%		+12.63%	+83.67%

May. 08	Sichuan Kelun-biotech Biopharmaceutical to Place 3.6 Million Shares; Inks Subscription Deal for 4.4 Million Shares	MT
May. 06	Kelun-Biotech's Lung Cancer Drug Advances to Phase 2 Trials in US; Shares Up 8%	MT

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd, formerly Sichuan Kelun Biotech Biopharmaceutical Co Ltd, is a China-based company mainly engaged in the research and development, production, and sales of drugs. The Company is mainly engaged in the research and development, production, and sales of biopharmaceuticals, chemical raw materials, and chemical drug formulations. The Company's products are mainly used for the treatment of breast cancer, non-small cell lung cancer, Gastrointestinal cancer and other non tumor diseases.

Number of employees: 1,446

HKD in Million	2022	Weight	2023	Weight	Delta
Novel Drugs 100.0 %	935	100.0 %	1,702	100.0 %	+82.08%

HKD in Million	2022	Weight	2023	Weight	Delta
United States 99.2 %	849	90.8 %	1,689	99.2 %	+98.92%
China 0.5 %	66	7.0 %	8	0.5 %	-87.31%
Other Countries 0.3 %	20	2.2 %	5	0.3 %	-74.20%

Managers	Title	Age	Since
Jun You Ge CEO	Chief Executive Officer	51	21-02-07
Ze Jian Zhou DFI	Director of Finance/CFO	41	22-02-24
Xiang Yang Tan CTO	Chief Tech/Sci/R&D Officer	61	21-07-04
Xiao Ping Jin CTO	Chief Tech/Sci/R&D Officer	47	21-09-05
Yi Wei Zhang PRN	Corporate Officer/Principal	68	18-01-08
Yi Feng PRN	Corporate Officer/Principal	59	20-11-30
Wai Sum Fung SEC	Corporate Secretary	41	23-01-29

Members of the board	Title	Age	Since
Ge Xin Liu FOU	Founder	73	16-11-21
Jin Ping Jin BRD	Director/Board Member	52	23-02-14
Si Chuan Liu BRD	Director/Board Member	40	16-11-21
Peng Wan BRD	Director/Board Member	48	21-02-11
De Gui Lai CHM	Chairman	52	21-02-11
Jun You Ge CEO	Chief Executive Officer	51	21-02-07
Wen Wei Tu BRD	Director/Board Member	57	23-02-14
Hong Mei Song BRD	Director/Board Member	41	19-05-17
Qiu Yan Yang BRD	Director/Board Member	39	17-08-17
Yan Qing BRD	Director/Board Member	40	20-12-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	92,571,094	91,645,383 ( 99.00 %)	0	55.25 %
Stock B	1	126,624,405	29,458,980 ( 23.26 %)	0

Name	Equities	%	Valuation
SICHUAN KELUN PHARMACEUTICAL CO., LTD. 56.34 %	71,345,543	56.34 %	1 413 M $
MERCK & CO., INC. 10.62 %	13,443,693	10.62 %	266 M $
Ge Xin Liu 10.09 %	12,782,700	10.09 %	253 M $
IDG Capital Partners Co., Ltd. 3.666 %	4,642,191	3.666 %	92 M $
Jun Li 3.317 %	4,200,000	3.317 %	83 M $
Wellington Management Group LLP 2.282 %	2,889,419	2.282 %	57 M $
Jing Yi Wang 2.251 %	2,850,000	2.251 %	56 M $
RTW Investments LP 1.528 %	1,934,400	1.528 %	38 M $
Wellington Management Hong Kong Ltd. 0.8860 %	1,121,841	0.8860 %	22 M $
China Universal Asset Management Co., Ltd. 0.8535 %	1,080,700	0.8535 %	21 M $

Name	Equities	%	Valuation
SICHUAN KELUN PHARMACEUTICAL CO., LTD. 52.66 %	78,777,842	52.66 %	1 560 M $
Jing Yi Wang 1.905 %	2,850,000	1.905 %	56 M $
Jun You Ge 0.9827 %	1,470,000	0.9827 %	29 M $
Hong Mei Song 0.2106 %	315,000	0.2106 %	6 M $
De Gui Lai 0.1965 %	294,000	0.1965 %	6 M $
Hao Feng 0.1965 %	294,000	0.1965 %	6 M $
Yan Qing 0.1872 %	280,000	0.1872 %	6 M $
Qiu Yan Yang 0.1497 %	224,000	0.1497 %	4 M $

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

No. 666 Xinhua Avenue Chengdu Cross-Strait Science and

611100, Chengdu

address Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.(6990)

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

189 HKD

Average target price

184 HKD

Spread / Average Target

-2.62%

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+83.67%	5.3B
VERTEX PHARMACEUTICALS INCORPORATED	+3.91%	109B
REGENERON PHARMACEUTICALS, INC.	+10.87%	105B
ARGENX SE	+1.28%	22.25B
BIONTECH SE	-13.14%	22.09B
GENMAB A/S	-7.05%	18.68B
WUXI APPTEC CO., LTD.	-38.36%	17.58B
BEIGENE, LTD.	-10.66%	16.85B
NEUROCRINE BIOSCIENCES, INC.	+3.75%	13.76B
SAREPTA THERAPEUTICS, INC.	+36.70%	12.46B

Bio Therapeutic Drugs